4//SEC Filing
Novak Alfred J 4
Accession 0001213900-22-065696
CIK 0001841330other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 10:15 AM ET
Size
5.4 KB
Accession
0001213900-22-065696
Insider Transaction Report
Form 4
Novak Alfred J
Director
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-10-21+100,000→ 100,000 totalExercise: $1.06From: 2023-10-21Exp: 2032-10-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to Mr. Novak's continued service as a director, one-half vesting on the first anniversary of the grant date, and the remaining 50% vesting on the second anniversary of the grant date.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001388862
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 10:15 AM ET
- Size
- 5.4 KB